| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Drug | 36 | 2005 | 56 | 5.850 |
Why?
|
| Blood Platelets | 25 | 2006 | 74 | 2.810 |
Why?
|
| Agmatine | 13 | 2013 | 16 | 2.330 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 18 | 2003 | 38 | 2.170 |
Why?
|
| Clonidine | 24 | 2005 | 47 | 1.930 |
Why?
|
| Depressive Disorder | 18 | 2006 | 166 | 1.880 |
Why?
|
| Imidazoline Receptors | 39 | 2006 | 40 | 1.870 |
Why?
|
| Neuroblastoma | 2 | 2022 | 128 | 1.580 |
Why?
|
| Imidazoles | 17 | 2005 | 124 | 1.570 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2005 | 184 | 1.330 |
Why?
|
| Carrier Proteins | 9 | 2003 | 287 | 1.220 |
Why?
|
| Probiotics | 1 | 2022 | 25 | 0.870 |
Why?
|
| Depressive Disorder, Major | 4 | 2009 | 102 | 0.860 |
Why?
|
| Brain | 11 | 2004 | 1268 | 0.840 |
Why?
|
| Brassica | 1 | 2021 | 14 | 0.800 |
Why?
|
| Coculture Techniques | 1 | 2021 | 96 | 0.780 |
Why?
|
| Adrenergic alpha-Agonists | 9 | 2003 | 33 | 0.720 |
Why?
|
| Radioligand Assay | 18 | 2006 | 61 | 0.720 |
Why?
|
| Ureohydrolases | 2 | 2013 | 3 | 0.710 |
Why?
|
| Guanidines | 2 | 2013 | 17 | 0.700 |
Why?
|
| Brain Chemistry | 4 | 2003 | 134 | 0.680 |
Why?
|
| Receptors, Adrenergic, alpha | 8 | 1991 | 18 | 0.650 |
Why?
|
| Neuroprotective Agents | 3 | 2013 | 231 | 0.620 |
Why?
|
| Animals | 49 | 2020 | 14307 | 0.590 |
Why?
|
| Humans | 61 | 2022 | 34853 | 0.520 |
Why?
|
| Rats | 20 | 2020 | 3261 | 0.520 |
Why?
|
| Desipramine | 7 | 2006 | 10 | 0.520 |
Why?
|
| Bipolar Disorder | 3 | 2011 | 46 | 0.520 |
Why?
|
| Antihypertensive Agents | 4 | 2005 | 284 | 0.510 |
Why?
|
| Methoxyhydroxyphenylglycol | 5 | 1998 | 15 | 0.500 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 42 | 0.440 |
Why?
|
| Yohimbine | 7 | 2000 | 26 | 0.430 |
Why?
|
| Drug Discovery | 1 | 2013 | 77 | 0.430 |
Why?
|
| Binding Sites | 14 | 2003 | 597 | 0.430 |
Why?
|
| Iodine Radioisotopes | 8 | 2003 | 33 | 0.430 |
Why?
|
| Piperazines | 1 | 2013 | 109 | 0.430 |
Why?
|
| Bupropion | 3 | 2000 | 10 | 0.420 |
Why?
|
| Male | 37 | 2009 | 18870 | 0.400 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2009 | 4 | 0.390 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2003 | 29 | 0.390 |
Why?
|
| Databases, Genetic | 1 | 2011 | 90 | 0.390 |
Why?
|
| Adult | 27 | 2009 | 11034 | 0.380 |
Why?
|
| Antidepressive Agents | 3 | 2000 | 53 | 0.370 |
Why?
|
| Metallothionein | 8 | 1987 | 21 | 0.360 |
Why?
|
| Proteins | 4 | 2003 | 352 | 0.350 |
Why?
|
| Cyclohexanols | 1 | 2009 | 7 | 0.350 |
Why?
|
| Norepinephrine | 8 | 2006 | 107 | 0.350 |
Why?
|
| Epinephrine | 6 | 2003 | 35 | 0.340 |
Why?
|
| Imipramine | 3 | 1997 | 8 | 0.340 |
Why?
|
| Reference Values | 8 | 2009 | 204 | 0.340 |
Why?
|
| Middle Aged | 22 | 2009 | 9642 | 0.340 |
Why?
|
| Female | 37 | 2009 | 19873 | 0.330 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 120 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2013 | 1534 | 0.310 |
Why?
|
| Nitric Oxide Synthase | 3 | 2005 | 103 | 0.310 |
Why?
|
| Blood Pressure | 3 | 2003 | 613 | 0.300 |
Why?
|
| Protein Isoforms | 2 | 2003 | 121 | 0.290 |
Why?
|
| Amino Acid Motifs | 2 | 2003 | 85 | 0.290 |
Why?
|
| Liver | 9 | 1999 | 447 | 0.280 |
Why?
|
| Depression | 5 | 2003 | 664 | 0.280 |
Why?
|
| DNA, Complementary | 5 | 2004 | 175 | 0.280 |
Why?
|
| Zinc | 6 | 1987 | 114 | 0.280 |
Why?
|
| Medulla Oblongata | 3 | 2005 | 33 | 0.280 |
Why?
|
| RNA, Messenger | 6 | 2003 | 1152 | 0.280 |
Why?
|
| Metalloproteins | 6 | 1983 | 25 | 0.260 |
Why?
|
| Platelet Activation | 2 | 2003 | 3 | 0.260 |
Why?
|
| Monoamine Oxidase | 2 | 2006 | 31 | 0.260 |
Why?
|
| Platelet Count | 2 | 2006 | 17 | 0.260 |
Why?
|
| Down-Regulation | 6 | 2009 | 420 | 0.250 |
Why?
|
| Harmine | 1 | 2003 | 2 | 0.250 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 19 | 0.240 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 968 | 0.240 |
Why?
|
| Psychiatry | 1 | 2003 | 24 | 0.240 |
Why?
|
| Hippocampus | 2 | 2013 | 546 | 0.240 |
Why?
|
| Frontal Lobe | 1 | 2003 | 49 | 0.240 |
Why?
|
| Alternative Splicing | 1 | 2003 | 82 | 0.240 |
Why?
|
| Cell Communication | 1 | 2003 | 93 | 0.230 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2006 | 13 | 0.230 |
Why?
|
| Lactobacillus | 1 | 2022 | 15 | 0.220 |
Why?
|
| Exploratory Behavior | 1 | 2003 | 72 | 0.220 |
Why?
|
| Amygdala | 1 | 2003 | 110 | 0.220 |
Why?
|
| Immune Sera | 5 | 2000 | 59 | 0.220 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 153 | 0.210 |
Why?
|
| Up-Regulation | 4 | 1998 | 490 | 0.210 |
Why?
|
| Glycols | 3 | 1990 | 6 | 0.210 |
Why?
|
| Neurons | 4 | 2003 | 1130 | 0.210 |
Why?
|
| Tritium | 8 | 2000 | 48 | 0.210 |
Why?
|
| Astrocytes | 1 | 2003 | 203 | 0.210 |
Why?
|
| Membrane Fluidity | 2 | 1991 | 11 | 0.210 |
Why?
|
| Mice, Mutant Strains | 3 | 1987 | 78 | 0.200 |
Why?
|
| Taraxacum | 1 | 2021 | 1 | 0.200 |
Why?
|
| Circadian Rhythm | 3 | 1994 | 212 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2013 | 1802 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 338 | 0.200 |
Why?
|
| Spinacia oleracea | 1 | 2021 | 8 | 0.200 |
Why?
|
| Electric Impedance | 1 | 2021 | 23 | 0.200 |
Why?
|
| Menstrual Cycle | 2 | 1998 | 34 | 0.200 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 48 | 0.200 |
Why?
|
| P-Selectin | 1 | 2000 | 5 | 0.200 |
Why?
|
| Biological Availability | 1 | 2021 | 84 | 0.200 |
Why?
|
| Oxidopamine | 2 | 2005 | 18 | 0.200 |
Why?
|
| Peptides | 1 | 2003 | 308 | 0.200 |
Why?
|
| Epithelium | 1 | 2021 | 74 | 0.190 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 44 | 0.190 |
Why?
|
| Tetracycline | 1 | 2020 | 17 | 0.190 |
Why?
|
| Postmenopause | 1 | 2000 | 125 | 0.190 |
Why?
|
| Carboxy-Lyases | 3 | 2004 | 4 | 0.180 |
Why?
|
| Macrophages | 1 | 2003 | 431 | 0.180 |
Why?
|
| Feces | 1 | 2020 | 110 | 0.180 |
Why?
|
| Dystonia | 1 | 1999 | 3 | 0.180 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 8 | 0.180 |
Why?
|
| Integrins | 3 | 2003 | 49 | 0.180 |
Why?
|
| Cerebral Ventricles | 1 | 1999 | 23 | 0.180 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 107 | 0.180 |
Why?
|
| Cell Membrane | 8 | 1997 | 360 | 0.180 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 396 | 0.170 |
Why?
|
| Animals, Newborn | 4 | 2013 | 323 | 0.170 |
Why?
|
| Mice | 13 | 2003 | 5668 | 0.170 |
Why?
|
| Milk | 4 | 1987 | 48 | 0.170 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 68 | 0.170 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1999 | 75 | 0.170 |
Why?
|
| Posture | 2 | 1997 | 57 | 0.170 |
Why?
|
| Binding, Competitive | 6 | 1999 | 103 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2128 | 0.160 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1998 | 13 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2003 | 2333 | 0.160 |
Why?
|
| CHO Cells | 4 | 2005 | 107 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2003 | 541 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2009 | 1349 | 0.160 |
Why?
|
| Idazoxan | 4 | 2000 | 10 | 0.160 |
Why?
|
| Cricetinae | 4 | 2005 | 217 | 0.160 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1997 | 8 | 0.150 |
Why?
|
| Orientation | 1 | 1997 | 29 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 355 | 0.150 |
Why?
|
| Postural Balance | 1 | 1997 | 29 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 480 | 0.150 |
Why?
|
| Brain Stem | 1 | 1997 | 46 | 0.150 |
Why?
|
| Blotting, Western | 5 | 2006 | 834 | 0.150 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 1996 | 3 | 0.140 |
Why?
|
| PC12 Cells | 5 | 2003 | 84 | 0.140 |
Why?
|
| Fluoxetine | 1 | 1996 | 10 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 984 | 0.140 |
Why?
|
| Aged | 8 | 2003 | 6448 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1124 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2000 | 243 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1490 | 0.130 |
Why?
|
| Hypotension | 2 | 2005 | 21 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 17 | 0.120 |
Why?
|
| Affinity Labels | 3 | 2000 | 7 | 0.120 |
Why?
|
| Statistics as Topic | 2 | 2003 | 111 | 0.120 |
Why?
|
| Lactation | 3 | 1987 | 38 | 0.120 |
Why?
|
| Rabbits | 3 | 2005 | 278 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2013 | 74 | 0.120 |
Why?
|
| Milk Proteins | 3 | 1981 | 28 | 0.110 |
Why?
|
| Personality Inventory | 2 | 2009 | 73 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2013 | 110 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2013 | 197 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 1996 | 281 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 99 | 0.110 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 237 | 0.110 |
Why?
|
| Time Factors | 3 | 2006 | 1681 | 0.110 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 34 | 0.100 |
Why?
|
| Cloning, Molecular | 4 | 2004 | 310 | 0.100 |
Why?
|
| Cell Line | 3 | 2003 | 1289 | 0.100 |
Why?
|
| Neurotoxins | 2 | 2003 | 52 | 0.100 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 57 | 0.100 |
Why?
|
| Suicide | 2 | 2003 | 114 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2005 | 406 | 0.090 |
Why?
|
| Chromatography, Gas | 1 | 1989 | 16 | 0.090 |
Why?
|
| COS Cells | 4 | 2004 | 62 | 0.090 |
Why?
|
| Molecular Weight | 3 | 2003 | 161 | 0.090 |
Why?
|
| Animals, Suckling | 2 | 1987 | 10 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 271 | 0.090 |
Why?
|
| Immunoblotting | 3 | 2003 | 170 | 0.090 |
Why?
|
| Naphazoline | 2 | 2000 | 2 | 0.090 |
Why?
|
| Organ Specificity | 2 | 1999 | 123 | 0.080 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 57 | 0.080 |
Why?
|
| Copper | 2 | 1987 | 101 | 0.080 |
Why?
|
| Transfection | 4 | 2004 | 496 | 0.080 |
Why?
|
| Cattle | 4 | 1998 | 472 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 1530 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 528 | 0.080 |
Why?
|
| Dizocilpine Maleate | 2 | 2005 | 45 | 0.080 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 7 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 1986 | 13 | 0.070 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 72 | 0.070 |
Why?
|
| Mice, Inbred C3H | 2 | 1983 | 83 | 0.070 |
Why?
|
| Ganglionic Stimulants | 1 | 2006 | 2 | 0.070 |
Why?
|
| Tobacco, Smokeless | 1 | 2006 | 18 | 0.070 |
Why?
|
| Locus Coeruleus | 1 | 2006 | 15 | 0.070 |
Why?
|
| Autoradiography | 2 | 2003 | 36 | 0.070 |
Why?
|
| Receptors, Adrenergic | 1 | 1985 | 11 | 0.070 |
Why?
|
| Morphine | 1 | 2005 | 80 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 1981 | 117 | 0.060 |
Why?
|
| Adolescent | 3 | 2000 | 5035 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 881 | 0.060 |
Why?
|
| Kinetics | 3 | 1996 | 650 | 0.060 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 60 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 26 | 0.060 |
Why?
|
| Cold Temperature | 1 | 2003 | 39 | 0.060 |
Why?
|
| Exons | 1 | 2003 | 80 | 0.060 |
Why?
|
| Cadmium Poisoning | 1 | 1983 | 2 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 92 | 0.060 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1983 | 9 | 0.060 |
Why?
|
| Protein Binding | 2 | 2003 | 913 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 91 | 0.060 |
Why?
|
| Arginine | 1 | 2003 | 62 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2003 | 98 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2003 | 122 | 0.060 |
Why?
|
| Epitopes | 1 | 2003 | 145 | 0.060 |
Why?
|
| Guanabenz | 1 | 2003 | 3 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 1983 | 69 | 0.060 |
Why?
|
| Biological Transport | 1 | 2003 | 175 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 66 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 149 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 122 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2004 | 139 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 101 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 131 | 0.060 |
Why?
|
| Benzazepines | 1 | 2003 | 29 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 141 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2003 | 429 | 0.050 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2003 | 103 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 74 | 0.050 |
Why?
|
| Genetic Variation | 2 | 1981 | 328 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 200 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2003 | 467 | 0.050 |
Why?
|
| Diphenylhexatriene | 2 | 1991 | 2 | 0.050 |
Why?
|
| Fetus | 4 | 2003 | 103 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 154 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2000 | 62 | 0.050 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 4 | 0.050 |
Why?
|
| Ruthenium Red | 1 | 2000 | 4 | 0.050 |
Why?
|
| Menopause | 1 | 2000 | 54 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 180 | 0.050 |
Why?
|
| Cell Survival | 1 | 2003 | 818 | 0.050 |
Why?
|
| Mitochondria | 1 | 2003 | 454 | 0.050 |
Why?
|
| Cytokines | 1 | 2003 | 569 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2000 | 100 | 0.050 |
Why?
|
| Staurosporine | 3 | 2003 | 35 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 27 | 0.040 |
Why?
|
| Cloning, Organism | 1 | 1999 | 22 | 0.040 |
Why?
|
| Apoptosis | 2 | 2003 | 1317 | 0.040 |
Why?
|
| Acrodermatitis | 1 | 1979 | 3 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 129 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1998 | 66 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 192 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 55 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 4012 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 125 | 0.040 |
Why?
|
| Pregnancy | 5 | 1987 | 1503 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1998 | 14 | 0.040 |
Why?
|
| Testis | 1 | 1999 | 185 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1998 | 34 | 0.040 |
Why?
|
| Oxazoles | 1 | 1997 | 19 | 0.040 |
Why?
|
| Base Sequence | 2 | 1998 | 932 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 570 | 0.040 |
Why?
|
| o-Phthalaldehyde | 1 | 1997 | 3 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 1995 | 1442 | 0.040 |
Why?
|
| Biperiden | 1 | 1997 | 1 | 0.040 |
Why?
|
| Maprotiline | 1 | 1997 | 1 | 0.040 |
Why?
|
| Nortriptyline | 1 | 1997 | 1 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 57 | 0.040 |
Why?
|
| Amitriptyline | 1 | 1997 | 9 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 257 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1996 | 6 | 0.040 |
Why?
|
| Kidney | 1 | 1999 | 322 | 0.040 |
Why?
|
| Phencyclidine | 1 | 1996 | 17 | 0.040 |
Why?
|
| Olfactory Bulb | 1 | 1997 | 48 | 0.040 |
Why?
|
| Lung | 1 | 1999 | 413 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 217 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 196 | 0.040 |
Why?
|
| Hypertension | 1 | 2003 | 770 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 555 | 0.030 |
Why?
|
| Ligands | 2 | 1991 | 317 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1999 | 1422 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2000 | 1961 | 0.030 |
Why?
|
| Dioxanes | 1 | 1993 | 10 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1994 | 22 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 2 | 2003 | 40 | 0.030 |
Why?
|
| Premenstrual Syndrome | 1 | 1993 | 12 | 0.030 |
Why?
|
| Morpholines | 2 | 2003 | 65 | 0.030 |
Why?
|
| Catecholamines | 1 | 1993 | 43 | 0.030 |
Why?
|
| Caspases | 2 | 2003 | 132 | 0.030 |
Why?
|
| Chromones | 2 | 2003 | 51 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2003 | 194 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 55 | 0.030 |
Why?
|
| Cell Death | 2 | 2003 | 260 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1992 | 21 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 50 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 27 | 0.030 |
Why?
|
| Fluorescence | 1 | 1991 | 117 | 0.020 |
Why?
|
| Species Specificity | 2 | 1983 | 233 | 0.020 |
Why?
|
| Affect | 1 | 1992 | 147 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1990 | 40 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1989 | 49 | 0.020 |
Why?
|
| Models, Statistical | 1 | 1990 | 171 | 0.020 |
Why?
|
| Cognition | 1 | 1992 | 373 | 0.020 |
Why?
|
| Animals, Wild | 1 | 1987 | 15 | 0.020 |
Why?
|
| Micelles | 1 | 1987 | 31 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1986 | 25 | 0.020 |
Why?
|
| Models, Biological | 1 | 1990 | 642 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 132 | 0.020 |
Why?
|
| Cell Separation | 1 | 1986 | 91 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1989 | 901 | 0.020 |
Why?
|
| Cadmium | 2 | 1983 | 56 | 0.020 |
Why?
|
| Chemistry | 1 | 1986 | 17 | 0.020 |
Why?
|
| Glass | 1 | 1986 | 15 | 0.020 |
Why?
|
| Filtration | 1 | 1986 | 14 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 53 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1987 | 115 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1987 | 209 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 72 | 0.020 |
Why?
|
| Nifedipine | 1 | 2005 | 12 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 34 | 0.020 |
Why?
|
| Hydrocortisone | 2 | 1983 | 72 | 0.020 |
Why?
|
| Naloxone | 1 | 2005 | 50 | 0.020 |
Why?
|
| Gestational Age | 2 | 1983 | 190 | 0.020 |
Why?
|
| Imidazolines | 1 | 2005 | 1 | 0.020 |
Why?
|
| 5,6-Dihydroxytryptamine | 1 | 2005 | 2 | 0.020 |
Why?
|
| Serotonin Agents | 1 | 2005 | 3 | 0.020 |
Why?
|
| Bradycardia | 1 | 2005 | 6 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2005 | 125 | 0.020 |
Why?
|
| Research Design | 1 | 1986 | 292 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 52 | 0.020 |
Why?
|
| Dopamine | 1 | 2006 | 232 | 0.020 |
Why?
|
| Serotonin | 1 | 2005 | 114 | 0.020 |
Why?
|
| Ornithine Decarboxylase | 1 | 2004 | 10 | 0.020 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 5 | 0.020 |
Why?
|
| DNA Probes | 1 | 2004 | 26 | 0.020 |
Why?
|
| Calcimycin | 1 | 2003 | 11 | 0.020 |
Why?
|
| Ionophores | 1 | 2003 | 12 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 22 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2003 | 6 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 24 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 18 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 27 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 55 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 59 | 0.010 |
Why?
|
| Nicotine | 1 | 2006 | 238 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1983 | 24 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 257 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1983 | 29 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 91 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2003 | 97 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2003 | 117 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 296 | 0.010 |
Why?
|
| Flavonoids | 1 | 2003 | 78 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 115 | 0.010 |
Why?
|
| Metals | 1 | 1983 | 95 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 7 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 51 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1981 | 3 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2002 | 18 | 0.010 |
Why?
|
| Lactose | 1 | 1981 | 13 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 392 | 0.010 |
Why?
|
| Trypsin | 1 | 1981 | 39 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1981 | 28 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 109 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 351 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1981 | 36 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 274 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1981 | 195 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 233 | 0.010 |
Why?
|
| Amino Acids | 1 | 1981 | 139 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 383 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 255 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 612 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1981 | 298 | 0.010 |
Why?
|
| Age Factors | 1 | 1982 | 1007 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 878 | 0.010 |
Why?
|
| Milk, Human | 1 | 1979 | 29 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 202 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1993 | 5 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1993 | 5 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1989 | 126 | 0.010 |
Why?
|
| Genes | 1 | 1983 | 58 | 0.000 |
Why?
|
| Cadmium Chloride | 1 | 1983 | 13 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1983 | 123 | 0.000 |
Why?
|
| DNA | 1 | 1983 | 549 | 0.000 |
Why?
|